NCT03614715 - Pharmacokinetics and Pharmacodynamics of CinnoVex (Interferon Beta-1a) Compared to Avonex (Interferon Beta-1a) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

February 12, 2019

Study Completion Date

February 12, 2019

Conditions

BioequivalenceHealthy

Interventions

DRUG

Interferon Beta-1A

A single dose of Interferon Beta-1A (Stage 1: 30 or 60 µg, stage 2: 30 µg) was administered IM to healthy subjects (cross over treatment)

Trial Locations (1)

CRST Oy, Clinical Research Services Turku Itäinen Pitkäkatu 4 B, 3rd floor, Turku